neurodegenerative diseases

drug launch launch takeoff

Pharma

IntraBio snags FDA nod in rare disease just days after Zevra

The FDA on Tuesday approved IntraBio’s levacetylleucine under the brand name Aqneursa to treat neurological symptoms of NPC in adults and kids.

Fraiser Kansteiner Sep 25, 2024 9:50am

stop light green

Zevra snags FDA approval for new lysosomal storage disorder med

Sep 20, 2024 1:54pm

ALS neurons brain synapses

Amylyx to pull failed ALS drug from market, cut 70% of staff

Apr 4, 2024 10:06am